Efficacy of the RTS, S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

…, J Sacarlal, JJ Aponte, A Leach, E Macete, J Milman… - The Lancet, 2004 - thelancet.com
Background Development of an effective malaria vaccine could greatly contribute to disease
control. RTS,S/AS02A is a pre-erythrocytic vaccine candidate based on Plasmodium …

Duration of protection with RTS, S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of …

PL Alonso, J Sacarlal, JJ Aponte, A Leach, E Macete… - The Lancet, 2005 - thelancet.com
Background RTS,S/AS02A is a pre-erythrocytic stage malaria vaccine that provides partial
protection against infection in malaria-naive adult volunteers and hyperimmune adults. A …

Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants

…, E Kahigwa, R Hirt, P Vounatsou, JJ Aponte… - The Lancet, 1997 - thelancet.com
Background Malaria and anaemia, especially that due to iron deficiency, are two leading
causes of morbidity worldwide. Little is known about the relative contribution of Plasmodium …

Genetic diversity and protective efficacy of the RTS, S/AS01 malaria vaccine

…, S Anderson, D Ansong, JJ Aponte… - … England Journal of …, 2015 - Mass Medical Soc
Background The RTS,S/AS01 vaccine targets the circumsporozoite protein of Plasmodium
falciparum and has partial protective efficacy against clinical and severe malaria disease in …

Placental pathology in malaria: a histological, immunohistochemical, and quantitative study

MR Ismail, J Ordi, C Menendez, PJ Ventura, JJ Aponte… - Human pathology, 2000 - Elsevier
To characterize the histological changes in malarial placentas and their relationship with
parity and maternal and cord parasitemias, we conducted a histological study on 1,179 …

Immunogenicity of the RTS, S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised …

…, S Abdulla, P Aide, J Sacarlal, JJ Aponte… - The Lancet infectious …, 2015 - thelancet.com
Background The RTS,S/AS01 malaria vaccine targets the circumsporozoite protein,
inducing antibodies associated with the prevention of Plasmodium falciparum infection. We …

Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis

…, AK Ditzen, H Schwacha, JJ Aponte… - Official journal of the …, 2001 - journals.lww.com
OBJECTIVES: The significance of small intestinal bacterial overgrowth in patients with
cirrhosis is not fully understood and its diagnostic criteria are not uniform. We examined the …

Safety of the RTS, S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

JJ Aponte, P Aide, M Renom, I Mandomando, Q Bassat… - The Lancet, 2007 - thelancet.com
Background Malaria remains a leading global health problem that requires the improved
use of existing interventions and the accelerated development of new control methods. We …

Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo …

JJ Aponte, D Schellenberg, A Egan, A Breckenridge… - The Lancet, 2009 - thelancet.com
Background Intermittent preventive treatment (IPT) is a promising strategy for malaria
control in infants. We undertook a pooled analysis of the safety and efficacy of IPT in infants (IPTi) …

Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia

…, FE Brinkmann, AK Ditzen, JJ Aponte… - The American journal of …, 2002 - Elsevier
OBJECTIVES: Systemic endotoxemia has been implicated in various pathophysiological
sequelae of chronic liver disease. One of its potential causes is increased intestinal absorption …